Xponance Inc. Has $513,000 Stake in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE)
Xponance Inc. grew its position in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) by 8.3% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 12,205 shares of the biopharmaceutical company’s stock after purchasing an additional 940 shares during the quarter. Xponance Inc.’s holdings in […]
